Picture [LSUS] – The Business Web Portal 650x65px
Document › Details

Teva Pharmaceutical Industries Ltd.. (8/3/17). "Press Relase: Teva Reports Second Quarter 2017 Financial Results". Jerusalem.

Organisations Organisation Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)
  Group Teva (Group)
  Organisation 2 Celltrion Inc. (KRX: 068270)
  Group Celltrion (Group)
Products Product Copaxone®
  Product 2 pharmaceutical
Person Person Peterburg, Yitzhak (Teva 201702– Interim CEO)

Record changed: 2019-06-09


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Teva (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top